{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:34:17Z","timestamp":1785774857706,"version":"3.56.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1097\/md.0000000000002167","type":"journal-article","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T05:34:56Z","timestamp":1449812096000},"page":"e2167","source":"Crossref","is-referenced-by-count":1,"title":["Functional Outcome After Lower Limb Amputation"],"prefix":"10.1097","volume":"94","author":[{"given":"Stefano","family":"Brunelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Iosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Traballesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20210309","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3109\/09638288.2012.717583","article-title":"Mid- to long-term factors influencing functional status of people affected by lower-limb amputation associated with hemiparesis due to stroke","volume":"35","author":"Brunelli","year":"2013","journal-title":"Disabil Rehabil"},{"key":"R2-24-20210309","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"J Vasc Surg"},{"key":"R3-24-20210309","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"R4-24-20210309","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.79.6.1180","article-title":"Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease","volume":"79","author":"Malinow","year":"1989","journal-title":"Circulation"},{"key":"R5-24-20210309","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00019501-199809010-00008","article-title":"Association between plasma homocysteine and peripheral arterial disease in older persons","volume":"9","author":"Aronow","year":"1998","journal-title":"Coronary Artery Dis"},{"key":"R6-24-20210309","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1078-5884(03)00381-2","article-title":"The incidence of hyperhomocysteinaemia in vascular patients","volume":"26","author":"Spark","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R7-24-20210309","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.97.5.437","article-title":"Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group","volume":"97","author":"Robinson","year":"1998","journal-title":"Circulation"},{"key":"R8-24-20210309","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2310\/6670.2007.00031","article-title":"Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-a-vis occlusive arterial disease","volume":"15","author":"Bhargava","year":"2007","journal-title":"Vascular"},{"key":"R9-24-20210309","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jvs.2003.07.011","article-title":"Family history is a major determinant of subclinical peripheral arterial disease in young adults","volume":"39","author":"Valentine","year":"2004","journal-title":"J Vasc Surg"},{"key":"R10-24-20210309","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0021-9150(98)00156-7","article-title":"The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis","volume":"141","author":"Verhoeff","year":"1998","journal-title":"Atherosclerosis"},{"key":"R11-24-20210309","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325.7374","author":"Wald","year":"2002","journal-title":"BMJ"},{"key":"R12-24-20210309","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(05)70152-5","article-title":"Homocysteine and stroke: evidence on a causal link from mendelian randomisation","volume":"365","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"R13-24-20210309","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/A:1005373209964","article-title":"The natural history of vascular disease in homocystinuria and the effects of treatment","volume":"20","author":"Wilcken","year":"1997","journal-title":"J Inherit Metab Dis"},{"key":"R14-24-20210309","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJMoa055227","article-title":"Homocysteine lowering and cardiovascular events after acute myocardial infarction","volume":"354","author":"B\u00f8naa","year":"2006","journal-title":"N Engl J Med"},{"key":"R15-24-20210309","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa060900","article-title":"Homocysteine lowering with folic acid and B vitamins in vascular disease","volume":"354","author":"Lonn","year":"2006","journal-title":"N Engl J Med"},{"key":"R16-24-20210309","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/jama.291.5.565","article-title":"Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial","volume":"291","author":"Toole","year":"2004","journal-title":"JAMA"},{"key":"R17-24-20210309","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/01.STR.0000185929.38534.f3","article-title":"Vitamin Intervention For Stroke Prevention trial: an efficacy analysis","volume":"36","author":"Spence","year":"2005","journal-title":"Stroke"},{"key":"R18-24-20210309","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease. A randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"R19-24-20210309","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1583\/08-2385.1","article-title":"Homocysteine, the cholesterol of the 21st century. Impact of hyperhomocysteinemia on patency and amputation-free survival after intervention for critical limb ischemia","volume":"15","author":"Heneghan","year":"2008","journal-title":"J Endovasc Ther"},{"key":"R20-24-20210309","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11239-011-0550-4","article-title":"Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties","volume":"32","author":"Cacciapuoti","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"R21-24-20210309","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1373\/clinchem.2003.021634","article-title":"Facts and recommendations about total homocysteine determinations: an expert opinion","volume":"50","author":"Refsum","year":"2004","journal-title":"Clin Chem"},{"key":"R22-24-20210309","first-page":"61","article-title":"Functional evaluation: the Barthel Index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md State Med J"},{"key":"R23-24-20210309","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","article-title":"Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence","volume":"131","author":"Eikelboom","year":"1999","journal-title":"Ann Intern Med"},{"key":"R24-24-20210309","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1583\/JEVT-12-3949MR.1","article-title":"The effects of normalizing hyperhomocysteinemia on clinical and operative outcomes in patients with critical limb ischemia","volume":"19","author":"Waters","year":"2012","journal-title":"J Endovasc Ther"},{"key":"R25-24-20210309","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2337\/diacare.27.7.1598","article-title":"Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study","volume":"27","author":"Tentolouris","year":"2004","journal-title":"Diabetes Care"},{"key":"R26-24-20210309","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","article-title":"Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial","volume":"123","author":"Bostom","year":"2011","journal-title":"Circulation"},{"key":"R27-24-20210309","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jvs.2005.04.015","article-title":"Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patients","volume":"42","author":"Taylor","year":"2005","journal-title":"J Vasc Surg"},{"key":"R28-24-20210309","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2340\/16501977-0393","article-title":"Predicting walking ability following lower limb amputation: a systematic review of the literature","volume":"41","author":"Sansam","year":"2009","journal-title":"J Rehabil Med"},{"key":"R29-24-20210309","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2340\/16501977-1046","article-title":"Can simple clinical tests predict walking ability after prosthetic rehabilitation?","volume":"44","author":"Sansam","year":"2012","journal-title":"J Rehabil Med"},{"key":"R30-24-20210309","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/09638288.2011.591888","article-title":"Geriatric rehabilitation of lower limb amputees: a multicenter study","volume":"34","author":"Spruit-van Eijk","year":"2012","journal-title":"Disabil Rehabil"},{"key":"R31-24-20210309","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/09638289809166097","article-title":"Prognostic factors in rehabilitation of above-knee","volume":"20","author":"Traballesi","year":"1998","journal-title":"Disabil Rehabil"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000002167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:55:16Z","timestamp":1620960916000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201512080-00024"}},"subtitle":["Is Hyperhomocysteinemia a Predictive Factor? An Observational Study"],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":31,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000002167","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}